/Investor DB

Seventure Partners — 2021 Investments

4 investments dated 2021 · listed companies and verified rows first · show all

Cytoki Pharmacytokipharma.cominMay 2021 · $45M

Cytoki is a biotech company developing IL-22-based therapeutics using lipidation technology to treat metabolic diseases such as obesity and type 2 diabetes, as well as conditions involving epithelial injury like inflammatory bowel disease.

BiotechHealthtechVærløse, DK

Rasmus Jorgensen(CEO & Founder)in

Co-investors+ND CapitalYsios Capital

Dopavisiondopavision.comJul 2021

Dopavision develops digital therapeutics that use selective ocular light stimulation delivered through consumer electronics to non-invasively activate the eye's signaling pathways.

Digital HealthHealthtechMedical Devices

Co-investorsBoehringer Ingelheim Venture Fund

Lecturiolecturio.comDec 2021

Lecturio provides an AI-augmented, all-in-one medical study platform combining video lectures, question banks, simulations, and clinical reasoning tools for medical and nursing students, healthcare professionals, and institutions such as universities, hospitals, and health systems.

AI & Machine LearningDigital HealthEdTech

Co-investorsSterling PartnersHoltzbrinck Digital GmbHHoltzbrinck Ventures

Proteon Pharmaceuticalsproteonpharma.comAug 2021

Proprietary phage development platform.

Co-investorsAqua SparkMontis CapitalMontis VC

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.